News
"China's bakery industry is evolving at breathtaking speed," noted Vergneau, stressing that "Our strategy focuses on ...
New subsidiary laws allow Beijing’s national security office to operate more effectively and openly. Read more at ...
SHENZHEN: Bored at a work meeting? For Chinese officials looking to rest their eyes on potted greens adorning conference ...
The test will initially be available at about 50 American research institutes and hospitals that specialise in Alzheimer’s ...
China has proposed a massive overhaul to its nationwide fisheries law, which, if passed, would align the nation’s fishing ...
Medical device maker Medtronic said on Wednesday it plans to separate its diabetes business, which houses its insulin pumps ...
In the face of the restructuring of global supply chains, HNC continues to serve as a vital international business platform for the global health industry, having always focused on expanding the ...
The first quarter of 2025 was both strategically and clinically significant for Neola Medical. The company strengthened its financial position through a successful directed share issue of approximatel ...
We assign a narrow moat rating for Alibaba Health due to its network effect from the number of healthcare merchants, pharmacies, and online doctors on its platform, and intangible assets that come ...
The transaction is expected to close in the third quarter subject to fulfillment of customary closing conditions, including receipt of required regulatory approvals and 3SBio shar ...
For companies in the food business whether local or export-driven understanding and complying with international regulations is now a key part of doing business. FSSAI: India’s homegrown safety ...
BEIJING, CHINA / ACCESS Newswire / May 19, 2025 / CASI Pharmaceuticals, Inc. (Nasdaq:CASI), ("CASI" or the "Company"), a Cayman incorporated biopharmaceutical company focused on developing and commerc ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results